Houlihan Lokey Advises Nippon Sangyo Suishin Kiko

Houlihan Lokey is pleased to announce that Nippon Sangyo Suishin Kiko Ltd. (NSSK) has sold its portfolio company, mighty myT, Inc. (mighty myT), to IQVIA. The transaction closed on May 1, 2025.

Founded in 1994 and headquartered in Tokyo, Japan, mighty myT is engaged in digital promotion and marketing outsourcing, as well as project management office services, to support clients in implementing digital transformation and marketing strategies. These services are provided primarily to industry-leading clients in the pharmaceutical industry and include the construction and operation of medical information portal sites, support in the implementation of marketing efforts leveraging digital technology, and administrative functions that work with client marketing departments to execute marketing activities.

Founded in 2014, NSSK is a private equity firm focused on Japanese companies. NSSK is composed of professionals with extensive experience in investment and management support at global companies. NSSK is dedicated to supporting Japanese businesses by leveraging global best practices, a diverse talent pool, training systems, and an international network. The firm provides both capital investment and hands-on management support to high-potential Japanese companies, with the goal of enhancing corporate value and creating employment opportunities.

Through this transaction, mighty myT seeks to further expand the scale of its digital marketing services to the pharmaceutical sector by leveraging the buyer group’s customer relationships.

RELATED: Healthcare Technology, Mergers & Acquisitions